Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer’s disease

Cholinesterase inhibitors (ChE-Is) are among the main drugs approved for the treatment of Alzheimer’s disease (AD). Rivastigmine in the form of a transdermal patch is an alternative delivery method, and can give greater treatment compliance. Objectives: To conduct a preliminary assessment of the neu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Dementia & Neuropsychologia
Egile Nagusiak: Gustavo Alves Andrade dos Santos, Paulo Renato Canineu, Donizette Gonçalves, Paulo Celso Pardi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Associação Neurologia Cognitiva e do Comportamento 2011
Gaiak:
Medicina
esterases
rivastigmine
acetylcholine
Alzheimer’s disease
Neuropsychiatric Inventory
Sarrera elektronikoa:https://www.redalyc.org/articulo.oa?id=339529033012
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak